McDonald Capital Investors’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,682
Closed -$264K 23
2023
Q2
$264K Buy
+5,682
New +$196K 0.02% 23

McDonald Capital Investors's DICE Position: Q3 2023 in Review

McDonald Capital Investors sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 5,682 shares — an estimated $264K sold.

McDonald Capital Investors first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $264K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • McDonald Capital Investors reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • McDonald Capital Investors sold 5,682 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $264K.
  • McDonald Capital Investors first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • McDonald Capital Investors's DICE Therapeutics, Inc. Common Stock position peaked at $264K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on McDonald Capital Investors's 13F filing for Q3 2023, filed 27 Oct 2023.